Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases
CONCLUSIONS: One in ten patients with EBC who underwent LN removal experienced a relapse, highlighting the strong need to prevent early recurrence.PMID:37638590 | DOI:10.1080/14737167.2023.2246652 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Valentina Perrone Elisa Giacomini Diego Sangiorgi Antonella Tamma Massimo Giovannitti Carlotta Buzzoni Luca Degli Esposti Source Type: research

An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+ with aortic stenosis in the UK
CONCLUSIONS: The exploratory analysis suggests that the novel tissue valve could be a cost-effective intervention for people over the age of 55 with AS who are suitable for SAVR in the UK.PMID:37638585 | DOI:10.1080/14737167.2023.2249611 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Robert Malcolm Ciara Buckley Judith Shore Angela Stainthorpe Belen Marti Andrea White Jens Deckert Matteo Vernia Jo ão L Carapinha Ana L ópez-Marco Nicolas Nikolaidis Olaf Wendler Source Type: research

Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases
CONCLUSIONS: One in ten patients with EBC who underwent LN removal experienced a relapse, highlighting the strong need to prevent early recurrence.PMID:37638590 | DOI:10.1080/14737167.2023.2246652 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Valentina Perrone Elisa Giacomini Diego Sangiorgi Antonella Tamma Massimo Giovannitti Carlotta Buzzoni Luca Degli Esposti Source Type: research

An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+ with aortic stenosis in the UK
CONCLUSIONS: The exploratory analysis suggests that the novel tissue valve could be a cost-effective intervention for people over the age of 55 with AS who are suitable for SAVR in the UK.PMID:37638585 | DOI:10.1080/14737167.2023.2249611 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Robert Malcolm Ciara Buckley Judith Shore Angela Stainthorpe Belen Marti Andrea White Jens Deckert Matteo Vernia Jo ão L Carapinha Ana L ópez-Marco Nicolas Nikolaidis Olaf Wendler Source Type: research

Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases
CONCLUSIONS: One in ten patients with EBC who underwent LN removal experienced a relapse, highlighting the strong need to prevent early recurrence.PMID:37638590 | DOI:10.1080/14737167.2023.2246652 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Valentina Perrone Elisa Giacomini Diego Sangiorgi Antonella Tamma Massimo Giovannitti Carlotta Buzzoni Luca Degli Esposti Source Type: research

Cost-utility analysis of multiple sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research

Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research

Cost-Utility analysis of Multiple Sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research

Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research

Cost-Utility analysis of Multiple Sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research

Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research

Cost-Utility analysis of Multiple Sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research

Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research

Cost-effectiveness of tumor necrosis factor-alpha inhibitors: a systematic review and meta-analysis of cost-utility studies
CONCLUSION: Based on the available evidence during the study period, TNF-a-i is not a cost-effective option for treating RA compared to other DMARDs. However, high heterogeneity and low confidence in GRADE quality assessment preclude the results from being generalizable.PMID:37604704 | DOI:10.1080/14737167.2023.2249610 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 21, 2023 Category: Health Management Authors: Sajith Kumar Bhavani Shankara Bagepally Source Type: research